SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunity
M. Manali, L. A. Bissett, J. Amat, N. Logan, S. Scott, E. Hughes, W. Harvey, R. Orton, E. Thomson, R. Gunson, M. Viana, B. Willett, P. R. Murcia
The paper examines how SARS-CoV-2 evolution and patient immunological history influence antibody breadth and potency against different variants.
bioRxiv · May 6, 2022Microbiology